Capricor Therapeutics, Inc.
CAPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001133869
No open-market purchases or sales by Capricor Therapeutics, Inc. insiders were filed in the last 90 days; 169 institutions reported holding it in 13F filings for Q2 2026, worth $941.6M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Capricor Therapeutics, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 75 | 1 | 108 | +34 |
| Shares | 8.37M | 125.0K | 17.3M | +9.08M (+110.2%) |
| Value | $127.3M | $1.90M | $239.1M | +$113.7M (+90.7%) |
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (51)
Institutions that held Capricor Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
Sold out (17)
Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Ikarian Capital, LLC | 300,000 | $4.56M |
| Point72 Asset Management, L.P. | 250,204 | $3.81M |
| StemPoint Capital LP | 93,638 | $1.42M |
| Schonfeld Strategic Advisors LLC | 90,365 | $1.37M |
| Boothbay Fund Management, LLC | 87,750 | $1.33M |
| Sphera Funds Management Ltd. | 61,698 | $938.4K |
| Virtu Financial LLC | 30,112 | $458.0K |
| Fred Alger Management, LLC | 26,241 | $399.1K |
| MYDA Advisors LLC | 24,000 | $365.0K |
| Main Street Financial Solutions, LLC | 22,650 | $344.5K |
| Two Sigma Securities, LLC | 17,139 | $260.7K |
| Balyasny Asset Management LLC | 14,999 | $228.1K |
| Sassicaia Capital Advisers LLC | 12,600 | $191.6K |
| LPL Financial LLC | 10,001 | $152.1K |
| Householder Group Estate & Retirement Specialist, LLC | 1,500 | $22.0K |
| Signaturefd, LLC | 393 | $5.98K |
| Capital Performance Advisors LLP | 91 | $1.38K |
Not filed for Q4 2024 yet (1)
Institutions that held Capricor Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Ghost Tree Capital, LLC | 125,000 | $1.90M |